Regeneron
Manufacturing · New York, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
777 Old Saw Mill River Rd, Tarrytown, Ne...Phone Number
(914) 847-7000Website
www.regeneron.comRevenue
$15.5 BillionStock Symbol
REGNIndustry
About Regeneron
Regeneron Org Chart
Is Regeneron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Regeneron, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Regeneron has new funding data
Earning: See what the market has to say on Regeneron recently announced quarterly report
Check out if Regeneron is spiking on competitors!
Click to see if Regeneron had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Regeneron
Product Launch: Get notified when Regeneron launches new products
Website visits: Recent activity has been detected on your website
Check if Regeneron has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Regeneron is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Regeneron is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Regeneron.
Regeneron financials insights
Gather financial insights about Regeneron, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock Offering
$91.4M
Stock Offering
$174.7M
Debt
$400M
Regeneron Tech Stack
A closer look at the technologies used by Regeneron
Most Recent Scoops
Regeneron News & Media
Robbins LLP Urges REGN Investors to Contact the Firm Before the September 14, 2026, Lead Plaintiff Deadline in the Class Action Against Regeneron Pharmaceuticals, Inc.
Robbins LLP is Investigating Allegations that Regeneron Therapeutics, Inc. (REGN) Misled Investors Regarding the Viability of its Phase III Fianlimab-LibtaVertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
They could both outperform the market over the medium term, but one appears to have a clear edge.REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Fraud Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure
SAN FRANCISCO, Sept. 3, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after its surprising revelations concerning a Phase 3 clinical trial of a therapy intended to...REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regeneron
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.... Read More
